NL-OMON47610已完成2 期
Arthritis Prevention In the Pre-clinical Phase of RA with Abatacept. - APIPPRA
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Male or female subjects, aged * 18 years.
- •- Arthralgia that is considered to be inflammatory in nature.
- •- ACPA and RF positive, or high titre ACPA.
- •- Able and willing to give written informed consent and comply with the
- •requirements of the study protocol.
排除标准
- •- Clinically apparent arthritis, as assessed by a rheumatologist.
- •- A history of inflammatory arthritis, as assessed by a rheumatologist.
- •- History or current use of DMARDs or biologics.
- •- History of oral or parenteral use of corticosteroids within the last 12 weeks.
- •- Co-morbidities requiring treatment with immunosuppressive or immune
- •modulating therapy.
- •- Chronic illnesses that would, in the opinion of the investigator, put the
- •subject at risk.
- •- Recipients of a live vaccine within 4 weeks of inclusion.
- •- Pregnant or breastfeeding
- •- Unable to give informed consent
研究者
相似试验
进行中（未招募）
1 期
Arthritis prevention with abataceptThe target population for therapeutic intervention will be subjects who carry serum autoantibodies (antibodies to citrullinated protein antigens – ACPArheumatoid factor – RF) and who have joint pains (arthralgia) but no joint swelling. These subjects are deemed to be at highest risk of developing rheumatoid arthritis.MedDRA version: 20.0Level: PTClassification code 10003239Term: ArthralgiaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2013-003413-18-NLeiden University Medical Center206
进行中（未招募）
1 期
Arthritis prevention with abataceptThe target population for therapeutic intervention will be subjects who carry serum autoantibodies (antibodies to citrullinated protein antigens – ACPArheumatoid factor – RF) and who have joint pains (arthralgia) but no joint swelling. These subjects are deemed to be at highest risk of developing rheumatoid arthritis.MedDRA version: 20.0 Level: PT Classification code 10003239 Term: Arthralgia System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2013-003413-18-GBKing’s College London206
已完成
不适用
Rheumatoid arthritis prevention with abatacept - long-term outcome studyMusculoskeletal DiseasesRheumatoid arthritis, unspecifiedRheumatoid arthritisISRCTN12680338Kings College London and Guy's and St Thomas' NHS Foundation Trust143
已完成
不适用
Arthritis Prevention In the Pre-clinical Phase of Rheumatoid Arthritis with AbataceptTopic: Musculoskeletal disordersSubtopic: Musculoskeletal (all Subtopics)Disease: MusculoskeletalMusculoskeletal DiseasesISRCTN46017566Guy's and St Thomas' NHS Foundation Trust213
已完成
不适用
STRategies in Early Arthritis ManagementPolyarthritis/rheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritisISRCTN56637846Jan van Breemen Institute (Netherlands)80